Most GLP-1a weight loss and type diabetes medications require a prior authorization (PA) from the insurance provider: FDA-approved weight loss medications: Contrave, Saxenda (liraglutide), Wegovy (semaglutide) Zepbound (tirzepatide) FDA-approved Diabetes medications: Rybelsis, Victoza (liraglutide), Ozempic (semaglutide), or Mounjaro (tirzepatide) If your insurance company says that they cover FDA-approved diabetes medications, it suggests coverage for patients with type 2 diabetes
Recent advances in medicine have introduced new options that target the body's metabolism to support more effective weight management
Our founder, Michal Clements, whose insights contributed significantly to this article, has over 30 years of experience in the food and beverage market strategy, and the team has recently been focusing on protein and weight loss in the food and beverage industry
Growing consumer awareness of obesity health risks and treatment options is driving increased consultation rates with endocrinology specialists